array:22 [ "pii" => "S1579212906603297" "issn" => "15792129" "doi" => "10.1016/S1579-2129(06)60329-7" "estado" => "S300" "fechaPublicacion" => "2004-08-01" "aid" => "60329" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica (SEPAR)" "copyrightAnyo" => "2004" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2004;40:386" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1542 "formatos" => array:3 [ "EPUB" => 72 "HTML" => 1024 "PDF" => 446 ] ] "itemAnterior" => array:18 [ "pii" => "S1579212906603285" "issn" => "15792129" "doi" => "10.1016/S1579-2129(06)60328-5" "estado" => "S300" "fechaPublicacion" => "2004-08-01" "aid" => "60328" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica (SEPAR)" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2004;40:385-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1564 "formatos" => array:3 [ "EPUB" => 68 "HTML" => 999 "PDF" => 497 ] ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the Editor</span>" "titulo" => "What Is Best for Lung Cancer Patients?" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "385" "paginaFinal" => "386" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Muñoz, I. Rubio Etxebarria, G. López-Vivanco" "autores" => array:3 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Muñoz" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Rubio Etxebarria" ] 2 => array:2 [ "nombre" => "G." "apellidos" => "López-Vivanco" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212906603285?idApp=UINPBA00003Z" "url" => "/15792129/0000004000000008/v1_201305150106/S1579212906603285/v1_201305150106/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the Editor</span>" "titulo" => "Author's Reply" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "386" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "I. Sampablo Lauro, J.I. Izquierdo" "autores" => array:2 [ 0 => array:3 [ "nombre" => "I." "apellidos" => "Sampablo Lauro" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff1" ] ] ] 1 => array:3 [ "nombre" => "J.I." "apellidos" => "Izquierdo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff2" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Sagrat Cor, Barcelona, Spain" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff1" ] 1 => array:3 [ "entidad" => "Servicio de Neumología, Hospital General, Guadalajara, Spain" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff2" ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "REFERENCES" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non small cell lung cancer tumors: single agent and combination chemotherapy studies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "DR Shalinsky" 1 => "J Brekken" 2 => "H Zou" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Cancer Res" "fecha" => "1999" "volumen" => "5" "paginaInicial" => "1905" "paginaFinal" => "1917" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10430098" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidermal growth factor receptor and cyclooxygenase-2 in non-small cell lung cancer: potential targets for chemoprevention and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C Richardson" 1 => "R Sharma" 2 => "G Cox" 3 => "K O'Byrne" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lung Cancer" "fecha" => "2003" "volumen" => "39" "paginaInicial" => "1" "paginaFinal" => "13" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12499088" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "¿Cuál debe ser el papel del neumólogo en el tratamiento quimioterapéutico del cáncer de pulmón?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "I Sampablo Lauro" 1 => "JL Izquierdo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2003" "volumen" => "39" "paginaInicial" => "483" "paginaFinal" => "484" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14588199" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Report of the working party of the “UEMS Monospeciality section on Pneumology” on training requirements and facilities in Europe" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J Dijkman" 1 => "J Martínez Gonzáles del Río" 2 => "R Loddenkemkper" 3 => "K Prowse" 4 => "N Siafakas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "1994" "volumen" => "7" "paginaInicial" => "1019" "paginaFinal" => "1022" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8050536" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical manifestations of lung cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L Hyde" 1 => "C Hyde" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "1974" "volumen" => "65" "paginaInicial" => "299" "paginaFinal" => "306" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4813837" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000004000000008/v1_201305150106/S1579212906603297/v1_201305150106/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/15792129/0000004000000008/v1_201305150106/S1579212906603297/v1_201305150106/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212906603297?idApp=UINPBA00003Z" ]
Journal Information
Vol. 40. Issue 8.
Pages 386 (August 2004)
Vol. 40. Issue 8.
Pages 386 (August 2004)
Letters to the Editor
Full text access
Author's Reply
Visits
3244
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
DR Shalinsky, J Brekken, H Zou.
Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non small cell lung cancer tumors: single agent and combination chemotherapy studies.
Clin Cancer Res, 5 (1999), pp. 1905-1917
[2]
C Richardson, R Sharma, G Cox, K O'Byrne.
Epidermal growth factor receptor and cyclooxygenase-2 in non-small cell lung cancer: potential targets for chemoprevention and treatment.
Lung Cancer, 39 (2003), pp. 1-13
[3]
I Sampablo Lauro, JL Izquierdo.
¿Cuál debe ser el papel del neumólogo en el tratamiento quimioterapéutico del cáncer de pulmón?.
Arch Bronconeumol, 39 (2003), pp. 483-484
[4]
J Dijkman, J Martínez Gonzáles del Río, R Loddenkemkper, K Prowse, N Siafakas.
Report of the working party of the “UEMS Monospeciality section on Pneumology” on training requirements and facilities in Europe.
Eur Respir J, 7 (1994), pp. 1019-1022
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)